Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Domany

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Bioinformatics (Oxford, England)|February 22, 2005
Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matricesD Tsafrir, I Tsafrir, L Ein-Dor, et al.
Oncogene|June 13, 2001
DNA microarrays identification of primary and secondary target genes regulated by p53K Kannan, N Amariglio, G Rechavi, et al.
Rejuvenation Research|September 23, 2008
Age-dependent spatial memory loss can be partially restored by immune activationN Ron-Harel, Y Segev, G M Lewitus, et al.
Leukemia|October 14, 2006
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cellsH Gal, N Amariglio, L Trakhtenbrot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2013
Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patientsF Ganci, A Sacconi, N Bossel Ben-Moshe, et al.
Cell Death and Differentiation|January 17, 2015
Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growthS Adi Harel, N Bossel Ben-Moshe, Y Aylon, et al.
Oncogene|July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.
Oncogene|February 28, 2024
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC -R Pradeep, A Zeisel, W J Köstler, et al.
Oncogene|April 11, 2025
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC -R Pradeep, A Zeisel, W J Köstler, et al.
Oncogene|December 6, 2011
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC-R Pradeep, A Zeisel, W J Köstler, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Bioinformatics (Oxford, England)|February 22, 2005
Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matricesD Tsafrir, I Tsafrir, L Ein-Dor, et al.
Oncogene|June 13, 2001
DNA microarrays identification of primary and secondary target genes regulated by p53K Kannan, N Amariglio, G Rechavi, et al.
Rejuvenation Research|September 23, 2008
Age-dependent spatial memory loss can be partially restored by immune activationN Ron-Harel, Y Segev, G M Lewitus, et al.
Leukemia|October 14, 2006
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cellsH Gal, N Amariglio, L Trakhtenbrot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2013
Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patientsF Ganci, A Sacconi, N Bossel Ben-Moshe, et al.
Cell Death and Differentiation|January 17, 2015
Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growthS Adi Harel, N Bossel Ben-Moshe, Y Aylon, et al.
Oncogene|July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal fillingC-R Pradeep, W J Köstler, M Lauriola, et al.
Oncogene|February 28, 2024
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC -R Pradeep, A Zeisel, W J Köstler, et al.
Oncogene|April 11, 2025
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC -R Pradeep, A Zeisel, W J Köstler, et al.
Oncogene|December 6, 2011
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesionsC-R Pradeep, A Zeisel, W J Köstler, et al.
Pageof 4